In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, Glaxosmithkline Pharmaceuticals has informed that it has attached Related Party Transactions, on consolidated basis, drawn in accordance with applicable accounting standards for period ended 31st March 2019.
The above information is a part of company’s filings submitted to BSE.